Clinical Trial Update: Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients [NA]

View source ↗

Summary

Clinical trial update evaluating extended intravenous beta-lactam therapy for serious Gram-negative infections in critically ill patients. The document lists Na…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-negative Bacterial Infections

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Gram-Negative Bacterial Infections | NA | Status: UNKNOWN